AVALON GLOBOCARE CORP (AVCO)

Avalon GloboCare Announces NASDAQ Ticker Symbol Change from “AVCO” to “ALBT”

Company to Begin Trading under New Symbol “ALBT” on November 10, 2022 Symbol Change Better Reflects Avalon’s New Focus on Laboratory Services and...

Avalon GloboCare Signs Definitive Agreement for Transformational Acquisition of Leading Laboratory with 2021 Unaudited Revenue in Excess of $25 Million

Company to acquire a majority interest in Laboratory Services MSO, LLC, a leading reference laboratory with 2021 unaudited revenue in excess of $25...

Avalon GloboCare Receives Allowance for Joint U.S. Patent

Jointly with MIT, the Company also Submitted a New U.S. Patent Application for QTY Glucose Transporters...

Avalon GloboCare Announces Publication Featuring QTY Code Technology in the Official Journal of the American Chemical Society

Findings support utility of QTY protein code as a novel platform to generate water-soluble proteins for wide spectrum of biomedical applications Reports...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Good morning! It's time for another dive into the biggest pre-market stock movers as we check out what's happening Thursday morning!

Avalon GloboCare Announces New Study Featuring AI-Enhanced Protein Design Technology Targeting Glucose Transporter Against Cancer

FREEHOLD, N.J., June 30, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of innovative cell-based technologies...

Avalon GloboCare to Present at the Jefferies 2022 Healthcare Conference

FREEHOLD, N.J., May 25, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of innovative cell-based technologies...

NASDAQ Biotech AVCO makes Big Moves Filing 16 New Patent Applications, Co-Inventors are leading International Universities & Cellular Therapy Developers; Avalon Globocare (NASDAQ: AVCO)

NASDAQ Biotech AVCO makes Big Moves Filing 16 New Patent Applications, Co-Inventors are leading International Universities and Cellular Therapy Developers; Avalon Globocare Corp. (NASDAQ: AVCO)

NASDAQ Roundtable: $JAZZ signs Licensing agreement with $HOWL Today: Can $AVCO a Leading global developer of cell-based Technologies and Therapeutics be next? Avalon Globocare Corp.  (NASDAQ: AVCO)

NASDAQ Roundtable: $JAZZ signs Licensing agreement with $HOWL Today: Can $AVCO a Leading global developer of cell-based Technologies & Therapeuticsbe next? Avalon Globocare Corp. (NASDAQ: AVCO)

Cell-based Technologies & Therapeutics Global Developer Expands its Immuno-Oncology (mRNA)-based Platform. IND Application on the Horizon for this rising NASDAQ Company: Avalon Globocare Corp (NASDAQ:

Cell-based Technologies and Therapeutics Global Developer Expands its Immuno-Oncology (mRNA)-based Platform. IND Application on the Horizon for this rising NASDAQ Company: Avalon Globocare Corp (NASDAQ: AVCO)

Leading global developer of cell-based technologies and therapeutics Expands its Cellular Immuno-Oncology Platform. NASDAQ Company Avalon Globocare Corp (NASDAQ: AVCO) could be the next big Biotech.

Leading global developer of cell-based technologies & therapeutics Expands its Cellular Immuno-Oncology Platform. NASDAQ Company Avalon Globocare Corp (NASDAQ: AVCO)could be the next big Biotech.

Avalon GloboCare Expands its Cellular Immuno-Oncology Platform with the Addition of Novel Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapies

Leveraging Avalon’s existing Flash-CARTM technology platform to develop next-generation mRNA-based CAR-NK cellular therapeuticsClinical development of...

Leading global developer of cell-based technologies and therapeutics Expands its Cellular Immuno-Oncology Platform. NASDAQ Company Avalon Globocare Corp (NASDAQ: AVCO) could be the next big Biotech.

Avalon Globocare Corps (NASDAQ: AVCO) Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients. AVCO could be the next big Biotech

NASDAQ Company offers Life Saving Medical Advances; AI & Immunotherapy for Cancer & Immune Related Diseases Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO)

NASDAQ Company offers Life Saving Medical Advances; AI and Immunotherapy for Cancer and Immune Related Diseases Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO)